Comorbidities in Anti-Cyclic Citrullinated Peptide Positive At-Risk Individuals Do Not Differ from Those Patients with Early Inflammatory Arthritis

Overview of attention for article published in Frontiers in Medicine, February 2018

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (65th percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter: 8 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 31 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 9 X posts from 8 X users, with an upper bound of 19,604 followers.

Comorbidities in Anti-Cyclic Citrullinated Peptide Positive At-Risk Individuals Do Not Differ from Those Patients with Early Inflammatory Arthritis. https://t.co/SJWkTzzIhh

09 Mar 2018

Reply Repost Favourite

RT @DrAiLynTan: Similar prevalence in #comorbidities among people with CCP antibodies but without inflammatory arthritis, compared to thos…

22 Feb 2018

Reply Repost Favourite

RT @DrAiLynTan: Similar prevalence in #comorbidities among people with CCP antibodies but without inflammatory arthritis, compared to thos…

21 Feb 2018

Reply Repost Favourite

RT @DrAiLynTan: Similar prevalence in #comorbidities among people with CCP antibodies but without inflammatory arthritis, compared to thos…

20 Feb 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.